Corticosteroid therapy in IgA nephropathy. - Wikidata - awgldk - TriplyDB

Corticosteroid therapy in IgA nephropathy.

Corticosteroid therapy in IgA nephropathy.

http://www.wikidata.org/entity/Q34249313

about

Recent advances in the understanding and management of IgA nephropathy New developments in the genetics, pathogenesis, and therapy of IgA nephropathy The Treatment of IgA Nephropathy The molecular phenotype of endocapillary proliferation: novel therapeutic targets for IgA nephropathy Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy IgA nephropathy with minimal change disease.Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases Optimal proteinuria target for renoprotection in patients with IgA nephropathy.Efficacy and safety of mycophenolate mofetil in patients with IgA nephropathy: an update meta-analysis Review of cases of IgA nephropathy.Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.Immunosuppressive agents versus steroids in the treatment of IgA nephropathy-induced proteinuria: A meta-analysis.Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.Efficacy and safety of calcineurin inhibitor treatment for IgA nephropathy: a meta-analysis Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.Primary glomerulonephritis: A review of important recent discoveries.Cytokine gene polymorphisms: Can these differentiate renal disease entities?Tinospora cordifolia: One plant, many roles.Novel drugs and intervention strategies for the treatment of chronic kidney disease.Effects of dexamethasone on angiotensin II-induced changes of monolayer permeability and F-actin distribution in glomerular endothelial cells.Progression of IgA nephropathy under current therapy regimen in a Chinese population.Multiple rare genetic variants co-segregating with familial IgA nephropathy all act within a single immune-related network.Association of systemic lupus erythematosus susceptibility genes with IgA nephropathy in a Chinese cohort Abelmoschus manihot - a traditional Chinese medicine versus losartan potassium for treating IgA nephropathy: study protocol for a randomized controlled trial.IgA nephropathy factors that predict and accelerate progression to end-stage renal disease.Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease.Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial.The Role of TNF Superfamily Member 13 in the Progression of IgA Nephropathy.Identification of novel molecular signatures of IgA nephropathy through an integrative -omics analysis.Corticosteroids in IgA Nephropathy: Lessons from Recent Studies.Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy?Inflammation in IgA nephropathy.Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.Role of immunosuppressive therapy and predictors of therapeutic effectiveness and renal outcome in IgA nephropathy with proteinuria.The effects of cytotoxic therapy in progressive IgA nephropathy.Recurrence of IgA nephropathy after kidney transplantation in steroid continuation versus early steroid-withdrawal regimens: a retrospective analysis of the UNOS/OPTN database.IgA Nephritis with Declining Renal Function: Treatment with Corticosteroids May Be Worthwhile.Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy.Personalized evaluation based on quantitative proteomics for drug-treated patients with chronic kidney disease.Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.

P2860

Q26766126-95EA5BFB-6FE5-49D8-BCB4-E1678E571A93 Q26786248-A1EC0BC3-EFEE-4354-933A-3A247BB4F80B Q27005109-78BD56D0-BCE0-4700-9BD0-B084B95517A2 Q28542039-F4B7A04C-8C7F-466D-919E-3B34AC376B0D Q28554822-42BE2CCF-E9E4-46A9-BDBE-933946117350 Q33715857-13E754C4-156F-496D-AF72-6C7C3F6AEE79 Q33838866-ED6494D4-F54C-42DA-89E6-A35DD69731EB Q33864287-0D2847BF-DE7B-4F22-93BF-7F30F8A4BA0D Q33919210-D09DD42F-F530-4E10-AD1F-267D2AEF3FF8 Q34747324-8375CC5E-B1CE-4E08-8AE1-C214E6058F30 Q34971424-AD349153-0C4F-47C8-A21B-9BF36609C789 Q35926941-0605F211-BFAD-4B34-A8F1-C9953D60A1E6 Q36077744-DE7B06DA-DFB7-4343-859D-5B635612F94D Q36279214-050A75BC-C3E1-4E90-9061-0D75B5A8898C Q36447934-ADFD52F9-05BB-476D-AD62-1FAEFCB14F79 Q36465902-19E6EB63-DDE2-482E-B09E-A139202FD95C Q36471839-F866E226-3892-4E0A-ABB3-B22C2CF0398A Q36817711-8466E857-577E-4FB2-8095-6CF4F8A99FD1 Q37219043-BC2DE334-913E-4A18-9939-E72A219D8EDC Q37289130-1F5709C5-42FA-4C62-AE46-5C680FFBCFFA Q37621529-F94371D7-CA12-453B-94A4-2BF43E0C393D Q37631861-B00D0099-2F0F-4C3D-92C8-35F26DAC4193 Q37682219-C75DC4B2-7117-47E1-A521-99DFD56B644E Q37747625-8E240E74-0B95-4649-A5F4-BE8B99549913 Q38138929-DE2C21EC-F513-4006-AD5F-E6C522D337FB Q38242833-600055BC-DB59-4192-941C-425E445C7CC3 Q38372995-21D7B847-B4E1-4DF3-B17D-0F4A6FED7D7C Q38409163-54F96013-541D-4670-9674-F8899700BFFD Q38613296-46B0128A-102B-44F6-A9B7-BDC5C480857E Q38817381-3DA121FB-9715-4621-8491-6E8C7C3DB144 Q38860793-501BD5AD-3DC9-4ABA-9956-78F7B841ED60 Q39178756-980BD847-D0C6-4BDD-9008-889810265741 Q39809045-9E09A738-8B7D-4547-8F48-E44771F05D03 Q40428635-0DC3D990-9A47-44B4-BFF0-2A29EE4F0860 Q40734312-DA57C0DC-C3AF-4360-B5A7-120116834D4C Q42691557-031BAB94-9CA0-4438-892E-5DCBCDF21CFD Q42925783-F3F3C6DF-9629-4EA2-AE3B-050FB2B35302 Q47107237-FF296B42-BD57-4EB9-8848-B76A8FAFA82E Q47324570-E747B049-A924-4BB7-81A8-0D5DE1A81281 Q47773361-057D2FAF-5341-4AB2-A066-FF2465B1F39A

P2860

Corticosteroid therapy in IgA nephropathy.

http://www.wikidata.org/entity/Q34249313

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Corticosteroid therapy in IgA nephropathy.

@ast

Corticosteroid therapy in IgA nephropathy.

@en

Corticosteroid therapy in IgA nephropathy.

@nl

type

label

Corticosteroid therapy in IgA nephropathy.

@ast

Corticosteroid therapy in IgA nephropathy.

@en

Corticosteroid therapy in IgA nephropathy.

@nl

prefLabel

Corticosteroid therapy in IgA nephropathy.

@ast

Corticosteroid therapy in IgA nephropathy.

@en

Corticosteroid therapy in IgA nephropathy.

@nl

P1433

Q34249313-83DFE011-BB82-4FB1-96FA-639074745AF5

P1476

Q34249313-B3E8779D-8851-41D7-8E44-86F85FE882A9

P2093

Q34249313-379EB0CF-12A0-49D8-A4F4-0B4CF20BC752

Q34249313-73DAE345-DC65-4242-983E-9864E0E064EE

Q34249313-938469D5-FF34-4D70-A807-5E03ECCDA3DC

Q34249313-97976B5A-235F-47C3-ADCF-86032F14646D

Q34249313-A0E1F436-4284-4106-A474-E491113EEA8D

Q34249313-BA8318AC-50ED-4676-B6E0-E6BD91D9BEE9

Q34249313-E309657C-E106-4131-BA1F-DF9EB49B2B8B

Q34249313-F3036D1B-C919-4907-AEFF-B0E5D27DF67D

P2860

Q34249313-05768410-9B4A-431F-B738-18F8AFDEA257

Q34249313-23ACF59A-9F5D-4E0B-BB82-02451AAF4B22

Q34249313-3466514E-ADD0-438A-B374-EE2C6D338A4A

Q34249313-5B70B476-8F0D-419C-8B98-21EF98E5E4A2

Q34249313-5EACD111-ABB2-4640-AF77-29AA07E4470F

Q34249313-626FF527-5F0D-4F80-ACCE-79D878A0CF22

Q34249313-7209A11E-D391-4DC4-AC72-9E689B4633F6

Q34249313-751D984B-9645-4859-B6DD-6A9786790778

Q34249313-93D7AF4E-9D2E-402B-8F6E-0BFFA4BA4E7C

Q34249313-95D7CADC-C6D4-4026-B9CA-E999D2403098

P304

Q34249313-882599FD-CBBC-47E3-8124-57D2E7975123

P31

Q34249313-78ebff4e-97fe-4c18-b90a-97286a928458

Q34249313-DCF2410B-F4F3-4D6C-9D14-58BBB3A6567C

P356

Q34249313-CD3F98BB-1D69-48C5-9401-298429EDA87A

P433

Q34249313-7FC45141-E39D-431F-9563-E558555C7986

P478

Q34249313-94AB0D84-064B-41BE-B283-17135E4612CB

P50

Q34249313-2AAE7AB1-BEB5-4776-B524-09C42322AFED

Q34249313-81DCDE78-DD6E-4DA6-B72D-FF4062794FD5

P577

Q34249313-74F3E00F-8C70-4111-B0CE-902BB2F1A952

P698

Q34249313-1CFE6404-E241-418A-BCA0-8813469A0491

P932

Q34249313-B2BCC9FE-B0B2-46C6-8A0A-085ED06299C9

P356

P1433

Journal of the American Society of Nephrology

P1476

Corticosteroid therapy in IgA nephropathy.

@en

P2093

Adeera Levin

http://www.w3.org/2001/XMLSchema#string

Damin Xu

http://www.w3.org/2001/XMLSchema#string

Haiyan Wang

http://www.w3.org/2001/XMLSchema#string

Hong Zhang

http://www.w3.org/2001/XMLSchema#string

Jicheng Lv

http://www.w3.org/2001/XMLSchema#string

Mark Woodward

http://www.w3.org/2001/XMLSchema#string

TESTING Study Group

http://www.w3.org/2001/XMLSchema#string

Xinxin Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Non-immunosuppressive treatment for IgA nephropathy

Immunosuppressive agents for treating IgA nephropathy

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

Measuring inconsistency in meta-analyses

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.

Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis.

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

The commonest glomerulonephritis in the world: IgA nephropathy.

Can meta-analyses be trusted?

Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity

P304

1108-1116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2011111112

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

David W. Johnson

P577

2012-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22539830

http://www.w3.org/2001/XMLSchema#string

P932

3358763

http://www.w3.org/2001/XMLSchema#string